Viewing Study NCT02588833


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-04-11 @ 7:47 AM
Study NCT ID: NCT02588833
Status: COMPLETED
Last Update Posted: 2021-01-11
First Post: 2015-10-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.
Sponsor: Apellis Pharmaceuticals, Inc.
Organization: